AEP cleaves Tau in vitro and in human Alzheimer’s disease (AD) brains, abolishing its microtubule stabilizing function, inducing Tau aggregation, and triggering neurodegeneration (Zhang et al., 2014). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.